Chanson International Holding manufactures and sells a range of bakery products, seasonal products, and beverage products for individual and corporate customers. It offers packaged bakery products, such as cakes, bread, sweets, and snacks; birthday cakes; made-in-store pastries; mooncakes and zongzi products; and other products, including sandwiches, salads, toasts, croissants, soups, and desserts, as well as beverages and juice products. The company sells its products through a chain of bakeries, as well as digital platforms and third-party online food ordering platforms. It also offers eat-in services in its stores. The company sells its bakery and other products under the George Chanson, Patisserie Chanson, and Chanson brand names. It operates in Xinjiang in the People's Republic of China; and New York City, the United States. The company was formerly known as formerly known as RON Holding Limited and changed its name to Chanson International Holding in December 2020. The company was incorporated in 2019 and is headquartered in Urumqi, China. Chanson International Holding operates as a subsidiary of Danton Global Limited.

Chanson International Holding

Lixiang Education Holding Co., Ltd., through its subsidiaries, provides high school education and vocational education in the People's Republic of China. It also engages in the operation of food procurement and information technology development businesses. The company was formerly known as Lianwai Education Group Limited and changed its name to Lixiang Education Holding Co., Ltd. in May 2020. The company was founded in 2001 and is headquartered in Lishui, the People's Republic of China.

Lixiang Education Holding Co., Ltd.

Quhuo Limited, through its subsidiaries, operates a workforce operational solution platform in the People's Republic of China. The company provides tech-enabled and end-to-end operational solutions to blue-chip on-demand consumer service businesses in industries with e-commerce exposure, including delivery, ride-hailing, housekeeping, and bike-sharing. It also offers on-demand delivery solutions for industry customers with focus on items, such as grocery, and prepared and fresh food; ride hailing solutions for ride-hailing companies; housekeeping solutions and other services for short-term rental properties and hotel cleaning services; and shared-bike maintenance solutions to address the demand for maintenance and distribution services from bike-sharing companies. In addition, the company develops computer software and applications. Quhuo Limited was founded in 2012 and is based in Beijing, the People's Republic of China.

Quhuo Limited

MicroCloud Hologram Inc. engages in the research and development, and application of holographic technology worldwide. It also provides holographic digital twin technology services and has a holographic digital twin technology resource library. The company is based in China.

MicroCloud Hologram Inc.

Graphjet Technology Sdn. Bhd. engages in the production of graphene and graphite raw materials. It utilizes palm kernel shells to produce single layer graphene and artificial graphite. Graphjet Technology Sdn. Bhd. is based in Kuala Lumpur, Malaysia.

Graphjet Technology

zSpace, Inc. provides augmented and virtual reality educational technology solutions for K-12 schools, and career and technical education markets in the United States and internationally. The company provides StudioA3, an application that allows teachers to build lessons for various subject using pre-made models; hardware products comprising stylus, eyewear, laptop, and power adapter products; and installation and/or training services. Its platform offers a range of educational tools designed for K-12 science, technology, engineering, and math lessons, as well as training skilled trades in areas, such as health sciences, automotive engineering/repair, and software programming and advanced manufacturing. The company was formerly known as Infinite Z, Inc. and changed its name to zSpace, Inc. in February 2013. The company was incorporated in 2006 and is based in San Jose, California.

zSpace, Inc.

Epsium Enterprise Limited engages in the import trading and wholesale of alcoholic beverages in China, France, Chile, Australia, the United States, and Scotland. It primarily offers wines and spirits. The company's brands include Moutai, Xijiu, Wuliangye, Remy Martin Cognac, Macallan, Cointreau, Piper Heidsieck Champagne, and Red & White Wines, as well as French Fine Wines, such as Petrus, Lafite, Latour, Mouton, Margaux, and Lynch Bages. It distributes its products through chain supermarkets, stores, clubs, restaurants, food courts, bars, hotels, and gaming companies. The company was formerly known as Shengtao Investment Development Limited and changed its name to Epsium Enterprise Limited in 2021. Epsium Enterprise Limited was incorporated in 2020 and is based in Macau, China.

Epsium Enterprise Limited Ordinary Shares

Meiwu Technology Company Limited operates as an online and mobile commerce company in the People's Republic of China. The company operates through Clean Food Platform, Restaurant, and others segments. The company offers green food, organic food, intangible cultural heritage food, agricultural products, and pollution-free products. It also engages the provision of restaurant services; and wholesale of agricultural products. The company was formerly known as Wunong Net Technology Company Limited and changes its name to Meiwu Technology Company Limited in August 2021. The company was incorporated in 2018 and is headquartered in Shenzhen, the People's Republic of China.

Meiwu Technology Company Limited

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Applied Therapeutics, Inc.

The Generation Essentials Group operates as a media and entertainment company. The Company specializes in covering fashion, arts, lifestyle, cultural, and entertainment publication, as well as operates in the movie production sector.

Generation Essentials Group

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

ESSA Pharma Inc.

Mint, Inc. Ltd. is a company that engages in the provision of interior design and fit works. The company offers design services including layout plans and sketches presented in the form of 3d technical drawing and design and fit out services. The company was founded in 2018 and is headquartered in Hong Kong.

Mint Incorporation Limited

Leslie's, Inc. operates as a direct-to-consumer pool and spa care brand in the United States. The company markets and sells pool and spa supplies and related products and services. It offers pool chemicals consisting of chlorine, sanitizers, water balancers, specialty chemicals, and algae control; pool covers, including winter, solar and safety covers, leaf nets, cover reels, and cover alternatives; pool equipment, which comprise pool cleaners, pool pumps, pool filters, pool heating, and lighting; and pools, such as above ground pools, soft side pools, above ground pools liners and equipment, ladders and rails, and diving boards. The company also provides pool maintenance products, including pool closing and opening supplies, filter catridges, chlorine floaters, backwash and vacuum hoses, and cleaning attachments; parts, such as automatic pool cleaner parts, pool filter and pump parts, and pool heater and heat pump parts; and safety, recreational, and fitness-related products. In addition, it provides pool equipment and repair services. The company markets its products through 952 company operated locations in 38 states and e-commerce websites. It serves the residential, professional, and commercial consumers. The company was founded in 1963 and is headquartered in Phoenix, Arizona.

Leslie's, Inc.

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposarcoma indications (MRCLS); in phase II clinical trials with SPEARHEAD-2 for patients with head and neck cancer; and in phase I clinical trials for urothelial, melanoma, head and neck, ovarian, non-small cell lung, esophageal and gastric, synovial sarcoma, and MRCLS cancers. The company is also developing ADP-A2AFP, which is in phase I clinical trials for hepatocellular carcinoma; and ADP-A2M4CD8, which is in phase I clinical trial for SPEAR T-cells focusing on treating patients with lung, gastroesophageal, head and neck, ovarian, and bladder cancers. It has a collaboration and license agreement with GSK; third party collaborations with Noile-Immune Biotech Inc., Alpine Immune Sciences, Inc., and National Center for Cancer Immune Therapy in Denmark; strategic alliance agreement with the MD Anderson Cancer Center; and co-development and co-commercialization agreement with Universal Cells, Inc. Adaptimmune Therapeutics plc also has a strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic T-cell therapies utilizing aß T-cell receptors. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.

Adaptimmune Therapeutics plc

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation. It is developing JNS101 that is in Phase II trials for the treatment of Friedreich's Ataxia, a rare disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS102, which is in Phase II trials for the treatment of mucopolysaccharidosis Type I. The company is also developing JNS107 that is in Phase II trials for the treatment of MELAS Syndrome; and JNS108, which is in Phase II trials for the treatment of mild cognitive impairment/early Alzheimer's disease. In addition, it is developing JNS109 for amyotrophic lateral sclerosis; JNS110 for traumatic brain injury/concussion; and JNS120 for covid-19 treatment. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. The company was founded in 2016 and is headquartered in Jupiter, Florida.

Jupiter Neurosciences, Inc.

LanzaTech Global, Inc. operates as a nature-based carbon refining company in the United States and internationally. The company transforms waste carbon into the chemical building blocks for consumer goods, such as sustainable fuels, fabrics, and packaging. LanzaTech Global, Inc. was founded in 2005 and is headquartered in Skokie, Illinois.

LanzaTech Global, Inc.

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

enVVeno Medical Corporation

REE Automotive Ltd. operates in the e-mobility business. The company develops REEcorner technology, which integrates vehicle drive components, including steering, braking, suspension, powertrain, and control into the arch of the wheel. The company also develops REEboard, a flat and modular EV chassis. The company is headquartered in Herzliya, Israel.

REE Automotive Ltd.

Houston American Energy Corp., an independent oil and gas company, engages in the exploration, development, and production of natural gas, crude oil, and condensate in the United States. Its oil and gas properties are located primarily in the Texas Permian Basin, the onshore Texas and Louisiana Gulf Coast region, and in the South American country of Colombia. As of December 31, 2021, the company owned interests in four gross wells. Houston American Energy Corp. was incorporated in 2001 and is based in Houston, Texas.

Houston American Energy Corp.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.

Jasper Therapeutics, Inc.

Discover stocks hovering near their 52-week lows by comparing current prices to each company's published range. This curated list surfaces potential rebound candidates for value-focused investors who track oversold opportunities across sectors.

#	Company	Industry	Price	Vs 52W High	Market Cap	Analyst Target	P/E	Dividend	DCF	Score	Value	Profit	Growth	Health
1	Chanson International Holding CHSN NASDAQ CN	Restaurants	$2.25 0.23 (5.64%)	-99.75% vs $886.40	$2.77 M	-	-11.99	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
2	Lixiang Education Holding Co.,... LXEH NASDAQ CN	Education & Tra…	$0.29 -0.07 (0.00%)	-99.43% vs $50.08	$226.47 K	-	-1.76	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
3	Quhuo Limited QH NASDAQ CN	Software - Appl…	$1.63 0.32 (-4.96%)	-99.04% vs $169.11	$148.05 M	-	360.45	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
4	MicroCloud Hologram Inc. HOLO NASDAQ CN	Hardware, Equip…	$3.19 -0.05 (-29.80%)	-99.14% vs $370.00	$44.25 M	-	0.64	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
5	Graphjet Technology GTI NASDAQ MY	Industrial Mate…	$2.29 0.00 (-35.96%)	-98.91% vs $210.00	$8.67 M	-	-0.58	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
6	zSpace, Inc. ZSPC NASDAQ US	Computer Hardwa…	$0.50 -0.03 (13.17%)	-98.46% vs $32.69	$26.36 M	$20.00	-1.08	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
7	Epsium Enterprise Limited Ordi... EPSM NASDAQ CN	Beverages - Win…	$2.60 -0.48 (NaN%)	-98.32% vs $155.00	$19.22 M	-	0.00	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
8	Meiwu Technology Company Limit... WNW NASDAQ CN	Specialty Retai…	$1.55 -0.03 (3.59%)	-97.79% vs $70.00	$5.92 M	-	3.96	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
9	Applied Therapeutics, Inc. APLT NASDAQ US	Biotechnology	$0.12 0.10 (-9.00%)	-98.88% vs $10.48	$46.53 M	$4.50	-4.85	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
10	Generation Essentials Group TGE NYSE FR	Media & Enterta…	$1.04 -0.90 (NaN%)	-97.19% vs $37.02	$33.03 M	-	0.00	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
11	ESSA Pharma Inc. EPIX NASDAQ CA	Biotechnology	$0.20 -0.00 (-1.59%)	-96.88% vs $6.45	$9.52 M	$8.04	-2.99	$1.69	-	0 / 100	- / 100	- / 100	- / 100	- / 100
12	Mint Incorporation Limited MIMI NASDAQ HK	Engineering & C…	$0.43 -2.55 (3.89%)	-96.89% vs $13.69	$44.28 M	-	-75.81	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
13	Leslie's, Inc. LESL NASDAQ US	Home Improvemen…	$2.40 -0.45 (-3.15%)	-96.69% vs $72.60	$34.44 M	$3.97	-0.19	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
14	Adaptimmune Therapeutics plc ADAP NASDAQ GB	Biotechnology	$0.05 -0.01 (0.66%)	-94.36% vs $0.86	$11.70 M	-	-0.37	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
15	Jupiter Neurosciences, Inc. JUNS NASDAQ US	Biotechnology	$1.10 -0.27 (-1.16%)	-94.36% vs $19.51	$49.74 M	-	-7.89	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
16	LanzaTech Global, Inc. LNZA NASDAQ US	Waste Managemen…	$15.04 -0.35 (-4.89%)	-94.51% vs $274.00	$31.22 M	-	-0.75	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
17	enVVeno Medical Corporation NVNO NASDAQ US	Medical - Devic…	$0.33 -0.05 (-1.47%)	-94.17% vs $5.62	$14.27 M	-	-0.83	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
18	REE Automotive Ltd. REE NASDAQ IL	Auto - Recreati…	$0.78 -0.12 (-9.57%)	-93.37% vs $11.72	$36.15 M	$1.00	-1.26	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
19	Houston American Energy Corp. HUSA AMEX US	Oil & Gas Explo…	$2.16 0.02 (NaN%)	-93.25% vs $32.00	$74.23 M	-	-19.63	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
20	Jasper Therapeutics, Inc. JSPR NASDAQ US	Biotechnology	$1.77 -0.03 (-17.84%)	-93.19% vs $26.05	$39.82 M	$54.50	-1.30	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100

52 Week Low Stocks

Discover stocks hovering near their 52-week lows by comparing current prices to each company's published range. This curated list surfaces potential rebound candidates for value-focused investors who track oversold opportunities across sectors.